108 related articles for article (PubMed ID: 27827510)
1. Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.
Rupiani S; Guidotti L; Manerba M; Di Ianni L; Giacomini E; Falchi F; Di Stefano G; Roberti M; Recanatini M
Org Biomol Chem; 2016 Nov; 14(46):10981-10987. PubMed ID: 27827510
[TBL] [Abstract][Full Text] [Related]
2. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
[TBL] [Abstract][Full Text] [Related]
3. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Vettraino M; Manerba M; Govoni M; Di Stefano G
Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
Han X; Sheng X; Jones HM; Jackson AL; Kilgore J; Stine JE; Schointuch MN; Zhou C; Bae-Jump VL
J Hematol Oncol; 2015 Jan; 8():2. PubMed ID: 25631326
[TBL] [Abstract][Full Text] [Related]
5. Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A.
Altamimi AS; Alafeefy AM; Balode A; Vozny I; Pustenko A; El Shikh ME; Alasmary FAS; Abdel-Gawad SA; Žalubovskis R
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):147-150. PubMed ID: 29199484
[TBL] [Abstract][Full Text] [Related]
6. Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells.
Fiume L; Vettraino M; Carnicelli D; Arfilli V; Di Stefano G; Brigotti M
Biochem Biophys Res Commun; 2013 Jan; 430(2):466-9. PubMed ID: 23237800
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer.
Moir JAG; Long A; Haugk B; French JJ; Charnley RM; Manas DM; Wedge SR; Mann J; Robinson SM; White SA
Pancreas; 2020; 49(10):1364-1371. PubMed ID: 33122526
[TBL] [Abstract][Full Text] [Related]
8. Lactate Dehydrogenase Inhibition: Biochemical Relevance and Therapeutical Potential.
Laganá G; Barreca D; Calderaro A; Bellocco E
Curr Med Chem; 2019; 26(18):3242-3252. PubMed ID: 28183261
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure.
Ferriero R; Nusco E; De Cegli R; Carissimo A; Manco G; Brunetti-Pierri N
J Hepatol; 2018 Aug; 69(2):325-335. PubMed ID: 29580866
[TBL] [Abstract][Full Text] [Related]
10. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells.
Manerba M; Di Ianni L; Govoni M; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2017 Jan; 96():37-44. PubMed ID: 27622920
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.
Rupiani S; Buonfiglio R; Manerba M; Di Ianni L; Vettraino M; Giacomini E; Masetti M; Falchi F; Di Stefano G; Roberti M; Recanatini M
Eur J Med Chem; 2015 Aug; 101():63-70. PubMed ID: 26114812
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.
Granchi C; Fortunato S; Meini S; Rizzolio F; Caligiuri I; Tuccinardi T; Lee HY; Hergenrother PJ; Minutolo F
J Agric Food Chem; 2017 Jul; 65(28):5639-5649. PubMed ID: 28643510
[TBL] [Abstract][Full Text] [Related]
15. LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells.
Manerba M; Di Ianni L; Govoni M; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2017 Jul; 105():91-98. PubMed ID: 28501492
[TBL] [Abstract][Full Text] [Related]
16. Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
Wendt EHU; Schoenrogge M; Vollmar B; Zechner D
Anticancer Res; 2020 Jan; 40(1):153-160. PubMed ID: 31892563
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor.
Xue JJ; Chen QY; Kong MY; Zhu CY; Gen ZR; Wang ZL
Eur J Med Chem; 2014 Jun; 80():1-7. PubMed ID: 24763359
[TBL] [Abstract][Full Text] [Related]
18. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds.
Granchi C; Calvaresi EC; Tuccinardi T; Paterni I; Macchia M; Martinelli A; Hergenrother PJ; Minutolo F
Org Biomol Chem; 2013 Oct; 11(38):6588-96. PubMed ID: 23986182
[TBL] [Abstract][Full Text] [Related]
19. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
20. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
